Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aditxt Inc (NQ: ADTX )

3.400 -0.570 (-14.36%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aditxt Inc

< Previous 1 2 3 4 5 Next >
Study Finds That Introducing Some Foods to Infants Early Reduces Risks of Allergies
Via Investor Brand Network
Study Highlights New Insights on Neurological Autoimmune Illnesses
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves One Step Closer to In-Human Trials with Completion of Preclinical Toxicity Study
Via Investor Brand Network
Researchers Believe Seasonal Allergies Are Worsening
Via Investor Brand Network
Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it Closer to First-in-Human Trials
From Aditxt, Inc.
Via Business Wire
Virtual Biopsies May Revolutionize Procedures Used in Heart Transplants
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies
Via Investor Brand Network
Exposures COVID-19
Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses
Via Investor Brand Network
Exposures COVID-19
Uncertainty Causes Patients with Systemic Autoimmune Conditions to Be Depressed
Via Investor Brand Network
New Breakthrough Suggests a Liver Can Survive for Days Before Transplantation
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Added to PMLS Menu of Testing Services
Via Investor Brand Network
Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Platform Provides Consumers and Physicians with Data Needed to Make Informed Health Decisions on COVID-19
Via Investor Brand Network
Exposures COVID-19
New Spike in COVID Infections, 1M+ Death Toll, Underscore Potential Value of Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Technologies
Via Investor Brand Network
Topics Death
Exposures COVID-19 Death
Study Says Some Allergies Lower Covid Infection Risk
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Engages IBN for Corporate Communications Expertise
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Platform ‘Is the Right Technology at the Right Time’
Via Investor Brand Network
Exposures COVID-19
Study Discovers Gene Defect That Causes Allergies, Autoimmune Illnesses
Via Investor Brand Network
BioMedNewsBreaks – Why Aditxt Inc. (NASDAQ: ADTX) Is ‘One to Watch’
Via Investor Brand Network
Exposures COVID-19
New Research Outlines Autoimmune Hepatitis Risk Factors after Liver Transplantation
Via Investor Brand Network
Aditxt Inc. (NASDAQ: ADTX) Planning Nationwide Rollout of its AditxtScore(TM) Immune Monitoring Platform
Via Investor Brand Network
Exposures COVID-19
Aditxt Inc. (NASDAQ: ADTX) Is ‘One to Watch’
Via Investor Brand Network
ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Aditxt, Inc. - ADTX
From Kuznicki Law PLLC
Via Business Wire
Aditxt, Inc. Partners with Guthy-Renker Affiliate GRS to Launch Consumer Awareness Campaign for AditxtScore™ to Accelerate Adoption and Revenue Growth
From Aditxt, Inc.
Via Business Wire
Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th
From Aditxt, Inc.
Via Business Wire
Aditxt to Participate in the 2022 Virtual Growth Conference
From Aditxt, Inc.
Via Business Wire
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
From Aditxt, Inc.
Via Business Wire
Aditxt, Inc. to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference From January 25th-27th, 2022
From Aditxt, Inc.
Via Business Wire
Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO
From Aditxt, Inc.
Via Business Wire
Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use
From Aditxt, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.